Kewaunee Q4 sales up 5%, adjusted EPS $1.55 vs $0.34; backlog rises to $155.6M

KEWAUNEE SCIENTIFIC CORP /DE/

2024-FY EPS reported $6.38 revenue$203,755,000

Q4 sales $56.7M (+5% YoY); GAAP net earnings $11.0M (diluted EPS $3.71) include two non-recurring items.
Adjusted pre-tax earnings $5.37M (+131% YoY); adjusted diluted EPS $1.55 vs $0.34.
Adjusted EBITDA for Q4 $6.28M vs $3.31M prior year; order backlog $155.6M (up from $147.9M a year ago).
Domestic segment sales $35.9M (+2.1% YoY); segment net earnings $3.41M vs $2.40M.
Non-recurring transactions impacted GAAP results; management provides adjusted non-GAAP metrics for comparability.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.